Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic Disease

Luca Moroni, Carlo Selmi, Claudio Angelini, Pier Luigi Meroni

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Flow-mediated dilation (FMD) represents a non-invasive marker of endothelial function to evaluate vascular homeostasis, which reflects the effects of several mechanisms, including vessel tone regulation, cell proliferation, and inflammatory responses. Beyond classical atherosclerotic risk factors such as arterial hypertension, diabetes mellitus, smoking, obesity, and dyslipidemia, chronic inflammation contributes to the endothelial dysfunction causing plaque formation and there is growing evidence of a significantly higher cardiovascular morbidity associated with autoimmune diseases. The endothelium reacts to several endogenous and exogenous stimuli, through surface receptors and intracellular signalling, and releases numerous vasoactive substances, including endothelins, prostacyclins, and nitric oxide (NO). Chronic inflammatory rheumatic diseases are commonly associated with decreased endothelial NO production, vascular damage, and premature atherosclerosis. Despite partially eclipsed by pulse wave velocity measure in the modern scientific literature, we provide a comprehensive overview and critically discuss the available data supporting FMD as a surrogate marker of endothelial function and, therefore, its potential role in predicting early atherosclerosis in patients with rheumatic diseases.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalArchivum Immunologiae et Therapiae Experimentalis
DOIs
StateAccepted/In press - Mar 30 2017

Fingerprint

Rheumatic Diseases
Blood Vessels
Dilatation
Atherosclerosis
Nitric Oxide
Prostaglandins I
Modern Literature
Pulse Wave Analysis
Endothelins
Dyslipidemias
Autoimmune Diseases
Endothelium
Diabetes Mellitus
Homeostasis
Obesity
Biomarkers
Smoking
Cell Proliferation
Hypertension
Inflammation

Keywords

  • Autoantibody
  • Cardiovascular risk
  • Chronic inflammation
  • Connective tissue disease
  • Psoriatic arthritis
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Evaluation of Endothelial Function by Flow-Mediated Dilation : a Comprehensive Review in Rheumatic Disease. / Moroni, Luca; Selmi, Carlo; Angelini, Claudio; Meroni, Pier Luigi.

In: Archivum Immunologiae et Therapiae Experimentalis, 30.03.2017, p. 1-13.

Research output: Contribution to journalArticle

@article{501123e930184b01accd1dd30beae5a2,
title = "Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic Disease",
abstract = "Flow-mediated dilation (FMD) represents a non-invasive marker of endothelial function to evaluate vascular homeostasis, which reflects the effects of several mechanisms, including vessel tone regulation, cell proliferation, and inflammatory responses. Beyond classical atherosclerotic risk factors such as arterial hypertension, diabetes mellitus, smoking, obesity, and dyslipidemia, chronic inflammation contributes to the endothelial dysfunction causing plaque formation and there is growing evidence of a significantly higher cardiovascular morbidity associated with autoimmune diseases. The endothelium reacts to several endogenous and exogenous stimuli, through surface receptors and intracellular signalling, and releases numerous vasoactive substances, including endothelins, prostacyclins, and nitric oxide (NO). Chronic inflammatory rheumatic diseases are commonly associated with decreased endothelial NO production, vascular damage, and premature atherosclerosis. Despite partially eclipsed by pulse wave velocity measure in the modern scientific literature, we provide a comprehensive overview and critically discuss the available data supporting FMD as a surrogate marker of endothelial function and, therefore, its potential role in predicting early atherosclerosis in patients with rheumatic diseases.",
keywords = "Autoantibody, Cardiovascular risk, Chronic inflammation, Connective tissue disease, Psoriatic arthritis, Rheumatoid arthritis",
author = "Luca Moroni and Carlo Selmi and Claudio Angelini and Meroni, {Pier Luigi}",
year = "2017",
month = "3",
day = "30",
doi = "10.1007/s00005-017-0465-7",
language = "English (US)",
pages = "1--13",
journal = "Archivum Immunologiae et Therapiae Experimentalis",
issn = "0004-069X",
publisher = "Birkhauser Verlag Basel",

}

TY - JOUR

T1 - Evaluation of Endothelial Function by Flow-Mediated Dilation

T2 - a Comprehensive Review in Rheumatic Disease

AU - Moroni, Luca

AU - Selmi, Carlo

AU - Angelini, Claudio

AU - Meroni, Pier Luigi

PY - 2017/3/30

Y1 - 2017/3/30

N2 - Flow-mediated dilation (FMD) represents a non-invasive marker of endothelial function to evaluate vascular homeostasis, which reflects the effects of several mechanisms, including vessel tone regulation, cell proliferation, and inflammatory responses. Beyond classical atherosclerotic risk factors such as arterial hypertension, diabetes mellitus, smoking, obesity, and dyslipidemia, chronic inflammation contributes to the endothelial dysfunction causing plaque formation and there is growing evidence of a significantly higher cardiovascular morbidity associated with autoimmune diseases. The endothelium reacts to several endogenous and exogenous stimuli, through surface receptors and intracellular signalling, and releases numerous vasoactive substances, including endothelins, prostacyclins, and nitric oxide (NO). Chronic inflammatory rheumatic diseases are commonly associated with decreased endothelial NO production, vascular damage, and premature atherosclerosis. Despite partially eclipsed by pulse wave velocity measure in the modern scientific literature, we provide a comprehensive overview and critically discuss the available data supporting FMD as a surrogate marker of endothelial function and, therefore, its potential role in predicting early atherosclerosis in patients with rheumatic diseases.

AB - Flow-mediated dilation (FMD) represents a non-invasive marker of endothelial function to evaluate vascular homeostasis, which reflects the effects of several mechanisms, including vessel tone regulation, cell proliferation, and inflammatory responses. Beyond classical atherosclerotic risk factors such as arterial hypertension, diabetes mellitus, smoking, obesity, and dyslipidemia, chronic inflammation contributes to the endothelial dysfunction causing plaque formation and there is growing evidence of a significantly higher cardiovascular morbidity associated with autoimmune diseases. The endothelium reacts to several endogenous and exogenous stimuli, through surface receptors and intracellular signalling, and releases numerous vasoactive substances, including endothelins, prostacyclins, and nitric oxide (NO). Chronic inflammatory rheumatic diseases are commonly associated with decreased endothelial NO production, vascular damage, and premature atherosclerosis. Despite partially eclipsed by pulse wave velocity measure in the modern scientific literature, we provide a comprehensive overview and critically discuss the available data supporting FMD as a surrogate marker of endothelial function and, therefore, its potential role in predicting early atherosclerosis in patients with rheumatic diseases.

KW - Autoantibody

KW - Cardiovascular risk

KW - Chronic inflammation

KW - Connective tissue disease

KW - Psoriatic arthritis

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85016636427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016636427&partnerID=8YFLogxK

U2 - 10.1007/s00005-017-0465-7

DO - 10.1007/s00005-017-0465-7

M3 - Article

AN - SCOPUS:85016636427

SP - 1

EP - 13

JO - Archivum Immunologiae et Therapiae Experimentalis

JF - Archivum Immunologiae et Therapiae Experimentalis

SN - 0004-069X

ER -